Washington Trust Advisors, Inc. Neurocrine Biosciences Inc Transaction History

Washington Trust Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$75.79 - $100.07 $201,222 - $265,685	-2,655 Reduced 37.68%	4,392 $428,000
Q1 2022 May 05, 2022	SELL	$72.45 - $94.81 $31,878 - $41,716	-440 Reduced 5.88%	7,047 $661,000
Q4 2021 Feb 11, 2022	BUY	$79.65 - $106.22 $596,339 - $795,269	7,487 New	7,487 $638,000

638

93.8M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Washington Trust Advisors, Inc. with notifications on news.